News
Salk Institute launches Neuroimmunology Initiative with $20 million gift from NOMIS Foundation
Scientists will explore the understudied crosstalk between the immune and nervous systems, and the role it plays in health and disease
LA JOLLA—The Salk Institute will receive $20 million over four years from the NOMIS Foundation to launch a new Neuroimmunology Initiative within the Institute’s NOMIS Centerfor Immunobiology and Microbial Pathogenesis. By funding research programs, faculty recruitment, and pilot grants, the generous gift will enable Salk scientists to develop a deep understanding of the crosstalk between the immune and nervous systems and the role it plays in health and disease.
“We are deeply grateful to the NOMIS Foundation for investing in neuroimmunology and in Salk,” says Salk President Gerald Joyce. “This funding will allow us to tackle currently unaddressed scientific questions, opening fundamentally new areas of scientific inquiry across human health and disease, and paving the way toward innovative therapeutic interventions for a wide range of disorders that have both a neurological and immunological component, such as Alzheimer’s disease, ALS, long COVID, and some forms of cancer."